https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-07-03 / Pathol. Oncol. Res. 2013 Jan;19(1):119-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-07-03 / Pathol. Oncol. Res. 2013 Jan;19(1):119-222012-07-03 00:00:002019-02-15 09:18:19Successful treatment of solitary bone metastasis of non-small cell lung cancer with bevacizumab and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-12-06 / Arch. Immunol. Ther. Exp. (Warsz.) 2012 Feb;60(1):69-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-12-06 / Arch. Immunol. Ther. Exp. (Warsz.) 2012 Feb;60(1):69-772011-12-06 00:00:002019-02-15 08:45:32Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-15 / Cancer Lett. 2012 Apr;317(1):56-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-15 / Cancer Lett. 2012 Apr;317(1):56-642011-11-15 00:00:002011-11-15 00:00:00Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:652011-06-17 00:00:002019-02-15 08:45:33Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-17 / Cancer Immunol. Immunother. 2011 Oct;60(10):1497-502
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-17 / Cancer Immunol. Immunother. 2011 Oct;60(10):1497-5022011-06-17 00:00:002019-02-15 08:45:34Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-442011-04-06 00:00:002011-04-06 00:00:00Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Therapy 2011 Jan;8(1):43-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Therapy 2011 Jan;8(1):43-542011-01-01 00:00:002019-02-15 08:35:15Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-03-12 / Lung Cancer 2010 Nov;70(2):188-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-03-12 / Lung Cancer 2010 Nov;70(2):188-942010-03-12 00:00:002019-02-15 08:45:35Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-572009-09-13 00:00:002019-02-15 08:34:56Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-92008-12-13 00:00:002008-12-13 00:00:00Mechanisms of murine dendritic cell antitumor dysfunction in aging
